2021
DOI: 10.3389/fgene.2021.753948
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis of Ovarian Neoplasms Using Nomogram in Combination With Ultrasound Image-Based Radiomics Signature and Clinical Factors

Abstract: Objectives: To establish and validate a nomogram integrating radiomics signatures from ultrasound and clinical factors to discriminate between benign, borderline, and malignant serous ovarian tumors.Materials and methods: In this study, a total of 279 pathology-confirmed serous ovarian tumors collected from 265 patients between March 2013 and December 2016 were used. The training cohort was generated by randomly selecting 70% of each of the three types (benign, borderline, and malignant) of tumors, while the r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 22 publications
(20 citation statements)
references
References 32 publications
0
18
0
Order By: Relevance
“…In this study, a large cohort of 600 patients was analyzed and more pathological subtypes were included, except for AML and clear cell RCC. Sex was the only clinical signature in the nomogram of this study, suggesting that clinical factors in renal masses may contribute minimally to the differentiation of benign from malignant renal masses as reported in other cancers including ovarian, breast, and lung cancers (38)(39)(40). This observation merits further investigation.…”
Section: Discussionmentioning
confidence: 62%
“…In this study, a large cohort of 600 patients was analyzed and more pathological subtypes were included, except for AML and clear cell RCC. Sex was the only clinical signature in the nomogram of this study, suggesting that clinical factors in renal masses may contribute minimally to the differentiation of benign from malignant renal masses as reported in other cancers including ovarian, breast, and lung cancers (38)(39)(40). This observation merits further investigation.…”
Section: Discussionmentioning
confidence: 62%
“…[ 36 ] Low Low Low Low Low Qi et al . [ 37 ] Low Low Low Low High Stefan et al . [ 63 ] Unclear Low Low Low High Wang et al [ 38 ] Low Low Low Unclear Unclear Martinez-Mas et al [ 39 ] High Low Low High High Zhang et al [ 40 ] High Unclear High High Low Acharya et al [ 41 ] High Low Low High High Aramendia-Vidaurreta et al [ 46 ] Unclear Low Low Low Unclear Khazendar et al [ 47 ] Unclear Low Low Low …”
Section: Resultsmentioning
confidence: 99%
“…In addition, the current study also showed that HE-4 level was an independent predictor for distinguishing benign and malignant ovarian tumors. Unlike previous studies ( 33 , 37 ), the level of CA-125 and HE4 were evaluated simultaneously in our study. This study showed that only the HE-4 level could be used as an independent predictor.…”
Section: Discussionmentioning
confidence: 99%